Yonghe Medical Group Co., Ltd.

SEHK:2279 Stock Report

Market Cap: HK$430.3m

Yonghe Medical Group Past Earnings Performance

Past criteria checks 0/6

Yonghe Medical Group's earnings have been declining at an average annual rate of -81.7%, while the Healthcare industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 8.1% per year.

Key information

-81.7%

Earnings growth rate

-81.3%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate-8.1%
Return on equity-57.3%
Net Margin-24.5%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Bounce 36% But Its Business Still Trails The Industry

Dec 12
Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Bounce 36% But Its Business Still Trails The Industry

Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Leap 60% Yet They're Still Not Telling The Full Story

Sep 30
Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Leap 60% Yet They're Still Not Telling The Full Story

Is Yonghe Medical Group (HKG:2279) Using Debt Sensibly?

May 24
Is Yonghe Medical Group (HKG:2279) Using Debt Sensibly?

It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks

Mar 31
It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks

Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?

Oct 19
Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?

The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically

Sep 08
The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically

Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value

Aug 19
Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value

Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture

Mar 31
Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture

Revenue & Expenses Breakdown

How Yonghe Medical Group makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SEHK:2279 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 241,850-4531,34929
31 Mar 241,813-4961,38429
31 Dec 231,777-5381,41929
30 Sep 231,635-4301,30726
30 Jun 231,492-3221,19623
31 Mar 231,453-2031,11021
31 Dec 221,413-841,02418
30 Sep 221,63861,08818
30 Jun 221,863951,15217
31 Mar 222,0161071,23615
31 Dec 212,1691181,32014
30 Sep 212,1291211,30713
30 Jun 212,0901251,29513
31 Mar 211,8641361,11812
31 Dec 201,63814794212
31 Dec 191,224367809
31 Dec 18934545588

Quality Earnings: 2279 is currently unprofitable.

Growing Profit Margin: 2279 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 2279 is unprofitable, and losses have increased over the past 5 years at a rate of 81.7% per year.

Accelerating Growth: Unable to compare 2279's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 2279 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).

Return on Equity

High ROE: 2279 has a negative Return on Equity (-57.26%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 00:27
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yonghe Medical Group Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yichi ZhangChina International Capital Corporation Limited
Junhao ZhangGuosen Securities Co., Ltd.
Liting WangHaitong International Research Limited